This was also true when we limited the study to lung adenocarcinoma cell lines harboring only clinically acknowledged EGFR mutations (EGFR p.E756_A750del ELREA, L858R, T790M, Supplementary Fig. 3H). The gene discussed is EGFR; the disease is lung adenocarcinoma.